Vitrolife's share buyback program completed

Rhea-AI Summary

Vitrolife AB has completed its share buyback program, repurchasing a total of 52,568 shares from July 15-16, 2021. This initiative was designed to meet obligations related to the long-term incentive program LTIP2021. The buyback was executed under the Market Abuse Regulation and concluded with a total transaction value of SEK 22,822,482 across the two days. Following this buyback, Vitrolife holds 52,568 shares out of a total of 118,195,878 shares outstanding.

Positive

• Completion of buyback program could enhance shareholder value.
• Strengthening of stock performance by reducing share supply.

Negative

• None.

GOTHENBURG, Sweden, July 19, 2021 /PRNewswire/ -- During the period July 15, 2021 until July 16, 2021, Vitrolife AB (publ) has repurchased a total of 52,568 shares as part of the buyback program introduced by the Board of Directors to secure the obligations of Vitrolife (including social security contributions) relating to the long-term incentive program LTIP2021. As a result, the buyback program, which Vitrolife announced on July 14, 2021, is hereby completed since the maximum amount of shares (52,568) has been repurchased.

The buyback program was carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU) No 2016/1052 ("Safe Harbour Regulation").

During the period July 15, 2021 until July 16, 2021, shares were repurchased as follows:

July 15, 2021:
Aggregated daily volume (number of shares): 26,284
Weighted average share price per day (SEK): 434,1554
Total daily transaction value (SEK): 11,411,341

July 16, 2021:
Aggregated daily volume (number of shares): 26,284
Weighted average share price per day (SEK): 434,1478
Total daily transaction value (SEK): 11,411,141

All acquisitions have been carried out on Nasdaq Stockholm by SEB on behalf of Vitrolife. Following the acquisitions above, Vitrolife's holding of own shares amounts to 52,568. The total number of shares in Vitrolife is 118,195,878.

Gothenburg, July 19, 2021

VITROLIFE AB (publ)
Thomas Axelsson, CEO

Queries should be addressed to:
Thomas Axelsson, CEO, tel 46 31 721 80 01
Mikael Engblom, CFO, tel 46 31 721 80 14

This information was brought to you by Cision http://news.cision.com
https://news.cision.com/vitrolife-ab--publ-/r/vitrolife-s-share-buyback-program-completed,c3386706

The following files are available for download:

https://mb.cision.com/Main/1031/3386706/1446222.pdf

share buyback program completed

View original content:https://www.prnewswire.com/news-releases/vitrolifes-share-buyback-program-completed-301336234.html

SOURCE Vitrolife AB (publ)

FAQ

What is the purpose of Vitrolife's share buyback program completed in July 2021?

The buyback program was aimed at fulfilling obligations related to the long-term incentive program LTIP2021.

How many shares did Vitrolife repurchase during the buyback program?

Vitrolife repurchased a total of 52,568 shares.

What was the total transaction value of Vitrolife's buyback program?

The total transaction value was SEK 22,822,482.

How many shares does Vitrolife hold after the buyback?

After the buyback, Vitrolife holds 52,568 shares.

What are the dates for Vitrolife's completed share buyback?

The buyback occurred from July 15 to July 16, 2021.